JAKE F. FELICE, ND, LMP  Mention of the endocannabinoid system (ECS) often brings to mind cannabis and its major constituent, tetrahydrocannabinol (THC), which binds [...]

NODE SMITH, ND Tohoku University scientists and their colleagues in Germany have revealed that a first-time exposure to only a brief period of brain hyperactivity resulted in an acute breakdown [...]

Vis Medicatrix Naturae  Carrie Decker, ND Any practitioner that has seen more than a handful of autoimmune disease cases knows how challenging their management can be. The laundry list [...]

Node Smith, ND Like in a science fiction novel, miniscule spacecrafts able to reach a specific site of the brain and influence the operation of specific types of neurons or drug delivery: [...]

Node Smith, ND A recent research study on the use of cannabis in treatment-resistant forms of epilepsy differs from previously held beliefs about CBD versus THC.1 The study, conducted in [...]

Node Smith, ND On April 19, 2018, an advisory panel from the Federal Food and Drug Administration (FDA) recommended a new drug to be approved for the treatment of epilepsy.1 The drug, Epidiolex, [...]

Node Smith, ND A study was recently published in the journal Neurology, that supports using mindfulness techniques to reduce seizures in people suffering from epilepsy.1 The lead author, Sheryl [...]

Eric Yarnell, ND, RH(AHG) Idiopathic epilepsy represents a serious clinical challenge. Though numerous anti-epileptic drugs exist, they often cause significant adverse effects. Any agents that [...]